category:Stocks

Explore the latest articles and insights about category:Stocks.

The Stripe IPO that isn't coming (yet)

The Stripe IPO that isn't coming (yet)
Stripe hit $106.7B valuation and first-ever profitability in 2024, processing $1.4T in payments. Yet founders say "no near-term IPO." Why the most anticipated tech IPO keeps delaying—and what it means for 150+ zombie unicorns trapped behind it.
category:Stocks

Databricks IPO: The AI data giant at peak bubble or perfect timing?

Databricks IPO: The AI data giant at peak bubble or perfect timing?
Databricks has emerged as the most valuable private technology company globally, reaching a $100+ billion valuation in September 2025 while generating over $4 billion in revenue with remarkable 50%+ growth. The company is strategically delaying its IPO until market conditions optimize, targeting 2025-2026, despite being operationally ready with positive free
category:Stocks

Unitree's $7 billion robot revolution is coming to market

Unitree's $7 billion robot revolution is coming to market
China's leading robotics manufacturer Unitree is officially preparing for an IPO on Shanghai's STAR Market by Q4 2025, targeting a $7 billion valuation that would mark the world's first major humanoid robotics public listing. The company, which has dominated global quadruped robot sales with
category:Stocks category:Tech

Why DeepSeek’s Potential Use of OpenAI Outputs May Not Constitute Theft

Why DeepSeek’s Potential Use of OpenAI Outputs May Not Constitute Theft
The recent controversy surrounding DeepSeek, the Chinese AI startup, and its alleged use of OpenAI-generated outputs to train its models has sparked heated debates in the tech and AI communities. OpenAI and Microsoft are investigating whether DeepSeek improperly obtained data from OpenAI's API, potentially violating terms of service.
category:Cup_Of_Coffee category:Tech category:Stocks

Promising Horizons: The Future of Antiviral Research and Development

Promising Horizons: The Future of Antiviral Research and Development
Leading pharmaceutical companies and academic researchers have made significant strides in enhancing existing treatments and discovering new therapeutic options.
category:Stocks

Voyager Therapeutics: A Promising Future in Neurogenetic Medicine

Voyager Therapeutics: A Promising Future in Neurogenetic Medicine
Voyager Therapeutics, a clinical-stage biotechnology company, is making remarkable strides in the field of neurogenetic medicine. Specializing in gene therapy to address neurological diseases, Voyager is on a mission to leverage human genetics to modify the course of these debilitating conditions and ultimately provide cures. The company’s innovative approaches
category:Stocks ticker:VYGR

The Sweet Future of Sugar Alternatives and Stock Market Potential

The Sweet Future of Sugar Alternatives and Stock Market Potential
As the world becomes increasingly health-conscious, the demand for sugar alternatives has skyrocketed. This surge is not just a boon for our waistlines but also a golden opportunity for investors looking to capitalize on the growing market. Let's delve into the trade-offs and health aspects of popular sugar
category:Stocks

Villeroy & Boch Preferred Share: A Value Stock Analysis

Villeroy & Boch Preferred Share: A Value Stock Analysis
a German value stock with a dividend.
category:Stocks ticker:VIB3.DE

The Case for Arrival - Round #2

The Case for Arrival - Round #2
KCGI merger, Dieter, Recession Proof sales, $40k per vehicle in government incentives, and insane under-valuation compared to peers all make this Arrival story extremely juicy for us.
category:Cup_Of_Coffee category:Stocks ticker:ARVL

Arrival: The EV bet of the century?

Arrival: The EV bet of the century?
If you have been an investor in Arrival and owned Arrival stock within the last year, chances are, you lost a lot of money. Is it your fault? We are inclined to say no. On the contrary, we still believe it might be the EV bet of the century.
category:Stocks category:Cup_Of_Coffee ticker:ARVL
category:Cup_Of_Coffee category:Tech category:Politics category:Culture category:Stocks category:Science ticker:MSFT ticker:GOOGL
coffee.link Context for the Present Politics Tech Stocks Culture Science Cup of Coffee Tech Stack Sign up Archive Newsletter Jobs Legal Info Privacy Policy Terms and Conditions Disclaimer Contact Us Authors